Marina N Protopopova

Sequella, Inc.

$5,540,511

Attributed

$5,540,511

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2006–14

$2M$1.5M$1M$500K$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$5,540,511 · 7

By mechanism

R01$2,988,449 · 1

UC1$1,214,283 · 1

R43$604,529 · 2

R41$600,000 · 1

R34$107,250 · 1

RC1$26,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Sequella, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis”

Judith S. Currier · University Of California Los Angeles$301,722,065
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
Sharon A Nachman · Johns Hopkins University$194,852,226

Research focus

TuberculosisLeadInfectionIn VivoMycobacterium TuberculosisDrug CandidateIn VitroSpecificityStructureAntibioticsSeriesDosePublic Health RelevanceSmall MoleculeMaximum Tolerated DoseDrug KineticsPharmaceutical PreparationsAntitubercular AgentsIn Vitro ActivityDiaminesEvaluationDrug ResistanceClinical TrialsPreclinical Study